1. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction 
Lucie M. Turcotte, Ashley Yingst, Michael R. Verneris 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 7, Pages (July 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Sarcopenic obesity. Increased adipose tissue present compared to lean individual, despite similar body mass. Frequently observed after hematopoietic cell transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Immune cells and adipose tissue. Anti-inflammatory immune cells present in lean adipose tissue, proinflammatory immune cells present in obese adipose tissue. Unknown immune cells present in adipose tissue after hematopoietic cell transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Timeline for potential metabolic syndrome risk factors throughout the hematopoietic cell transplantation process.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions